Vanguard Group Inc Gilead Sciences, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 119,364,226 shares of GILD stock, worth $13.4 Billion. This represents 0.22% of its overall portfolio holdings.

Number of Shares

119,364,226

Previous 117,470,825 1.61%

Holding current value

$13.4 Billion

Previous $13.2 Billion 0.54%

% of portfolio

0.22%

Previous 0.25%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$96.91 - $113.0 $183 Million - $214 Million	1,893,401 Added 1.61%	119,364,226 $13.2 Billion
Q1 2025 May 09, 2025	BUY	$89.14 - $117.41 $173 Million - $228 Million	1,942,433 Added 1.68%	117,470,825 $13.2 Billion
Q4 2024 Feb 11, 2025	BUY	$83.95 - $97.9 $15.6 Million - $18.2 Million	185,508 Added 0.16%	115,528,392 $10.7 Billion
Q3 2024 Nov 13, 2024	BUY	$66.59 - $83.99 $5.4 Million - $6.81 Million	81,110 Added 0.07%	115,342,884 $9.67 Billion
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $33.4 Million - $38.6 Million	529,199 Added 0.46%	115,261,774 $7.91 Billion
Q1 2024 May 10, 2024	BUY	$71.58 - $87.29 $208 Million - $254 Million	2,910,147 Added 2.6%	114,732,575 $8.4 Billion
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $10.1 Million - $11.5 Million	137,854 Added 0.12%	111,822,428 $9.06 Billion
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $125 Million - $136 Million	-1,684,076 Reduced 1.49%	111,684,574 $8.37 Billion
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $30 Million - $34.2 Million	394,253 Added 0.35%	113,368,650 $8.74 Billion
Q1 2023 Jul 14, 2023	BUY	$77.31 - $88.08 $129,107 - $147,093	1,670 Added 0.0%	112,974,397 $9.37 Billion
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $72.2 Million - $82.3 Million	934,403 Added 0.83%	112,972,727 $9.37 Billion
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $3.05 Million - $4.38 Million	-48,947 Reduced 0.04%	112,038,324 $9.62 Billion
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $101 Million - $115 Million	1,691,194 Added 1.53%	112,087,271 $6.91 Billion
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $276 Million - $311 Million	4,787,719 Added 4.53%	110,396,077 $6.82 Billion
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $11.3 Million - $14.2 Million	-195,441 Reduced 0.18%	105,608,358 $6.28 Billion
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $38.8 Million - $44.1 Million	598,438 Added 0.57%	105,803,799 $7.68 Billion
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $12.7 Million - $13.7 Million	187,419 Added 0.18%	105,205,361 $7.35 Billion
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $6.67 Billion - $7.28 Billion	105,017,942 New	105,017,942 $7.23 Billion

Others Institutions Holding GILD

# of Institutions

2,327

Shares Held

1.02B

Call Options Held

12.1M

Put Options Held

9.13M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $141B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Gilead Sciences, Inc. Transaction History